The first robot manufactured in Catalonia is already operating on patients at the Hospital Clínic of Barcelona. In 2024, it is expected to obtain registration from the European authorities and the next step will be to make the leap to the United States.
The operations carried out so far have been successfully completed and the manufacturing of more robotic units has already begun at the company’s plant in El Prat de Llobregat.
The objective of the project, as stated by Jaume Amat, CEO of Rob Surgical, is clear: “democratize and universalize precision surgery”. With this statement he exposes the desire to make precision surgery available to medium or small hospitals, such as regional hospitals in Catalonia.
Rob Surgical’s proposal is to make a robot that is much lower in cost and does not require such a large investment for the centers. Thus, other centers will be able to access digital surgery without having to make a large investment and patients will be able to be treated without having to travel to the capital’s large hospitals.
“This reduces the cost per operation to more than half of what each intervention with a current robot currently costs,” says Jaume Amat. It also highlights the advantage of the design of this surgical robot: it allows for more intensive use and very easy transportation, in such a way that operations could be performed in a center and the next day moved to another location, optimizing its performance.
